CAHNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends June 30
CARDINAL HEALTH INC
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Aug 11, 2026
$252.65−1.41 (-0.55%)
Close on Oct 19, 2026
- Market cap
- $59.12B
- P/E (TTM)
- 34.9
- Dividend yield
- 0.81%
CARDINAL HEALTH INC revenue by segment
By business segment
| Revenue | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmaceutical and Specialty Solutions | $234.83B | $204.64B | $210.02B | $188.81B | $164.60B | – | – | – | – | – | 92.4% | +14.8% |
| GMPD | $12.72B | $12.64B | $12.38B | $12.22B | $13.28B | – | – | – | – | – | 5.0% | +0.7% |
| Other Operating Segment | $6.79B | $5.38B | $4.51B | $4.02B | $3.52B | – | – | – | – | – | 2.7% | +26.2% |
| Pharmaceutical | – | – | – | $190.01B | $165.49B | $145.80B | $137.50B | $129.92B | $121.24B | $116.46B | – | – |
| Medical | – | – | – | – | – | – | $15.44B | $15.63B | $15.58B | $13.52B | – | – |
| Medical | – | – | – | $15.01B | $15.89B | $16.69B | $15.44B | $15.63B | – | – | – | – |
| Operating income | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmaceutical and Specialty Solutions | $2.78B | $2.26B | $2.02B | $1.88B | $1.64B | – | – | – | – | – | +23.3% |
| Other Operating Segment | $707.00M | $516.00M | $423.00M | $396.00M | $390.00M | – | – | – | – | – | +37.0% |
| GMPD | $258.00M | $135.00M | $92.00M | -$147.00M | -$64.00M | – | – | – | – | – | +91.1% |
| Pharmaceutical | – | – | – | $2.00B | $1.77B | $1.68B | $1.75B | $1.83B | $1.99B | $2.19B | – |
| Medical | – | – | – | – | – | – | $663.00M | $576.00M | $662.00M | $572.00M | – |
| Medical | – | – | – | $111.00M | $216.00M | $577.00M | $663.00M | $576.00M | – | – | – |
By product or service
By region
| Revenue | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $252.64B | $220.99B | $225.23B | $203.44B | $179.47B | $157.76B | $148.71B | $141.48B | $132.54B | $125.02B | 99.4% | +14.3% |
| Non-US [Member] | $1.71B | $1.67B | $1.68B | $1.62B | $1.92B | $4.73B | $4.23B | $4.07B | $4.28B | $4.97B | 0.7% | +2.2% |
From the segment and revenue-disaggregation notes of Cardinal Health's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.